FDA narrows drug label usage

被引：0
|
作者：
Elie Dolgin
机构：
来源：
Nature | 2009年 / 460卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cancer treatments limited to specific gene variants.
引用
收藏
页码：1069 / 1069
相关论文
共 50 条
  • [1] FDA narrows drug label usage
    Dolgin, Elie
    NATURE, 2009, 460 (7259) : 1069 - 1069
  • [2] FDA Narrows EUA for the Johnson & Johnson Vaccine
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1652): : 95 - 95
  • [3] FDA propose drug label changes for use in pregnancy
    Reactions Weekly, 2008, 1205 (1) : 1 - 1
  • [4] EXTRA-LABEL DRUG USAGE AND DRUG AVAILABILITY FOR THE SWINE PRACTITIONER
    SCHULTZ, R
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1984, 185 (03) : 322 - 322
  • [5] Drug maker found liable despite FDA warning label
    Nature, 2009, 458 (7235) : 137 - 137
  • [6] HGS narrows drug focus
    不详
    CHEMICAL & ENGINEERING NEWS, 2004, 82 (13) : 12 - 12
  • [7] The conundrum of off-label and unlicensed drug usage in neonatology
    Jain, Lucky
    JORNAL DE PEDIATRIA, 2012, 88 (06) : 449 - 451
  • [8] FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone
    Cohen, Barbara R.
    Mahoney, Karen M.
    Baro, Elande
    Squire, Claudia
    Beck, Melissa
    Travis, Sara
    Pike-McCrudden, Amanda
    Izem, Rima
    Woodcock, Janet
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22): : 2129 - 2136
  • [9] FDA Regulation of Off-label Drug Promotion Under Attack
    Kesselheim, Aaron S.
    Mello, Michelle M.
    Avorn, Jerry
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05): : 445 - 446
  • [10] FDA off-track on off-label drug promotion
    不详
    LANCET, 2007, 370 (9604): : 1976 - 1976
12345